
Lorraine Spector
Examiner (ID: 8276, Phone: (571)272-0893 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | STIC, 1647, 1812, 1646 |
| Total Applications | 788 |
| Issued Applications | 338 |
| Pending Applications | 71 |
| Abandoned Applications | 379 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6838794
[patent_doc_number] => 20030036134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/184631
[patent_app_country] => US
[patent_app_date] => 2002-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57323
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20030036134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10184631
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/184631 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 26, 2002 | Abandoned |
Array
(
[id] => 5710946
[patent_doc_number] => 20060052291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Chemically-modified progenipoietin conjugates'
[patent_app_type] => utility
[patent_app_number] => 10/481935
[patent_app_country] => US
[patent_app_date] => 2002-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14427
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052291.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481935 | Chemically-modified progenipoietin conjugates | Jun 13, 2002 | Abandoned |
Array
(
[id] => 6861125
[patent_doc_number] => 20030092133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Interleukins-21 and 22'
[patent_app_type] => new
[patent_app_number] => 10/153770
[patent_app_country] => US
[patent_app_date] => 2002-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 61241
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092133.pdf
[firstpage_image] =>[orig_patent_app_number] => 10153770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/153770 | Interleukins-21 and 22 | May 23, 2002 | Abandoned |
Array
(
[id] => 6874476
[patent_doc_number] => 20030194773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/152391
[patent_app_country] => US
[patent_app_date] => 2002-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63478
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20030194773.pdf
[firstpage_image] =>[orig_patent_app_number] => 10152391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/152391 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 20, 2002 | Abandoned |
| 10/130393 | Mutated IL-13 molecules and their uses | May 12, 2002 | Abandoned |
Array
(
[id] => 6829782
[patent_doc_number] => 20030180840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063671
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 45581
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063671
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063671 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 6, 2002 | Abandoned |
Array
(
[id] => 6829784
[patent_doc_number] => 20030180842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063675
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 45528
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063675 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 6, 2002 | Abandoned |
Array
(
[id] => 7269906
[patent_doc_number] => 20040058424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/140024
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 550
[patent_figures_cnt] => 550
[patent_no_of_words] => 59624
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058424.pdf
[firstpage_image] =>[orig_patent_app_number] => 10140024
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/140024 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 5, 2002 | Abandoned |
Array
(
[id] => 6843076
[patent_doc_number] => 20030148423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/140019
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 551
[patent_figures_cnt] => 551
[patent_no_of_words] => 63479
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10140019
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/140019 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | May 5, 2002 | Abandoned |
Array
(
[id] => 6731006
[patent_doc_number] => 20030187196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063520
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 45528
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20030187196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063520 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 30, 2002 | Abandoned |
Array
(
[id] => 6774845
[patent_doc_number] => 20030018183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063512
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 41925
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018183.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063512
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063512 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 30, 2002 | Abandoned |
Array
(
[id] => 6774834
[patent_doc_number] => 20030018172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Secreted transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063513
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 170
[patent_figures_cnt] => 170
[patent_no_of_words] => 41812
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20030018172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063513
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063513 | Secreted transmembrane polypeptides and nucleic acids encoding the same | Apr 30, 2002 | Abandoned |
Array
(
[id] => 6865143
[patent_doc_number] => 20030190669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/063521
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 169
[patent_figures_cnt] => 169
[patent_no_of_words] => 45549
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190669.pdf
[firstpage_image] =>[orig_patent_app_number] => 10063521
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/063521 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Apr 30, 2002 | Abandoned |
Array
(
[id] => 6650914
[patent_doc_number] => 20030104987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Methods of using the hyaluronan receptor for endocytosis'
[patent_app_type] => new
[patent_app_number] => 10/133172
[patent_app_country] => US
[patent_app_date] => 2002-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 25758
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104987.pdf
[firstpage_image] =>[orig_patent_app_number] => 10133172
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/133172 | Methods of using the hyaluronan receptor for endocytosis | Apr 24, 2002 | Abandoned |
Array
(
[id] => 6735183
[patent_doc_number] => 20030012818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Drug delivery matrices to enhance wound healing'
[patent_app_type] => new
[patent_app_number] => 10/132619
[patent_app_country] => US
[patent_app_date] => 2002-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11411
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20030012818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10132619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/132619 | Drug delivery matrices to enhance wound healing | Apr 24, 2002 | Abandoned |
Array
(
[id] => 6715912
[patent_doc_number] => 20030027260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Human Toll homologues'
[patent_app_type] => new
[patent_app_number] => 10/095627
[patent_app_country] => US
[patent_app_date] => 2002-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 28221
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027260.pdf
[firstpage_image] =>[orig_patent_app_number] => 10095627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/095627 | Human Toll homologues | Mar 10, 2002 | Abandoned |
Array
(
[id] => 5788309
[patent_doc_number] => 20020160944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Multifunctional single chain glycoprotein hormones'
[patent_app_type] => new
[patent_app_number] => 10/092357
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6659
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160944.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092357 | Multifunctional single chain glycoprotein hormones comprising three or more β subunits | Mar 4, 2002 | Issued |
Array
(
[id] => 7249982
[patent_doc_number] => 20050142105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Chimeric molecule for the treatment of th2-like cytokine mediated disorders'
[patent_app_type] => utility
[patent_app_number] => 10/497804
[patent_app_country] => US
[patent_app_date] => 2005-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 36030
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142105.pdf
[firstpage_image] =>[orig_patent_app_number] => 10497804
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497804 | Chimeric molecule for the treatment of th2-like cytokine mediated disorders | Feb 27, 2002 | Issued |
Array
(
[id] => 5921758
[patent_doc_number] => 20020115156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Connective tissue growth factor (CTGF) and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/080173
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11796
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115156.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080173
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080173 | Connective tissue growth factor (CTGF) and methods of use | Feb 18, 2002 | Abandoned |
Array
(
[id] => 6710488
[patent_doc_number] => 20030170237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'G-CSF receptor agonist antibodies and screening method therefor'
[patent_app_type] => new
[patent_app_number] => 10/071962
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 9073
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071962 | G-CSF receptor agonist antibodies and screening method therefor | Feb 7, 2002 | Abandoned |